CPIG
NVCR icon

Chicago Partners Investment Group’s NovoCure NVCR Stock Holding History

Chicago Partners Investment Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Sell
20,101
-4,334
-18% -$54.1K 0.01% 1212
2025
Q4 		$329K Buy
24,435
+4,255
+21% +$54.6K 0.01% 979
2025
Q3 		$270K Buy
20,180
+4,229
+27% +$56.5K 0.01% 1011
2025
Q2 		$263K Buy
+15,951
New +$278K 0.01% 910

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Chicago Partners Investment Group's NVCR Position: Q1 2026 in Review

Chicago Partners Investment Group reduced its NovoCure (NVCR) stake by 18% in Q1 2026, selling an estimated $54.1K and leaving 20,101 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #1212.

Chicago Partners Investment Group first reported a position in NVCR in Q2 2025 and has held it in 4 quarters since. The position peaked at $329K in Q4 2025. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Chicago Partners Investment Group held 20,101 shares of NovoCure worth $262K as of Q1 2026.
  • Chicago Partners Investment Group sold 4,334 NovoCure shares in Q1 2026, an estimated $54.1K.
  • NovoCure made up 0.01% of Chicago Partners Investment Group's portfolio in Q1 2026, its #1212 holding.
  • Chicago Partners Investment Group first reported a position in NovoCure in Q2 2025 and has held it in 4 quarters since.
  • Chicago Partners Investment Group's NovoCure position peaked at $329K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.